- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 52.84M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 53.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 53.8M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $167.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $125M |
| Capex | Q1 2026 · Mar 31, 2026 | $40.6M |
| Capex | Q1 2026 · Mar 31, 2025 | $26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $86.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $37.4M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.04B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.04B |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $15.3M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $15.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $501.6M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $482.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.77B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.85B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.78B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.51B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.64B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.37B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.8B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.59B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.42B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.23B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.41 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $3.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.42 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $3.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $241.5M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $212.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | $181.8M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $163.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $263.8M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $230.4M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $505.3M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $442.6M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.01B |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $922.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.52B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.37B |